The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice. [PDF]
Mediterr J Rheumatol, 2019 Kravvariti E, Kitas GD, Sfikakis PP.
europepmc +1 more source
Confirmation of COVID-19 infection status and reporting of Long COVID symptoms in a population-based birth cohort: No evidence of a nocebo effect. [PDF]
J Health PsycholMacleod-Hall CI, Munafò MR, Dyer ML.
europepmc +1 more source
Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect. [PDF]
Rheumatol Ther, 2017 Rezk MF, Pieper B.
europepmc +1 more source
To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars. [PDF]
Adv Ther, 2018 Rezk MF, Pieper B.
europepmc +1 more source
Correction to: To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars. [PDF]
Adv Ther, 2018 Rezk MF, Pieper B.
europepmc +1 more source
The nocebo effect challenges the non-medical infliximab switch in practice. [PDF]
Eur J Clin Pharmacol, 2018 Boone NW +10 more
europepmc +1 more source
The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies. [PDF]
J Manag Care Spec Pharm, 2018 Odinet JS, Day CE, Cruz JL, Heindel GA.
europepmc +1 more source
Beyond pharmacology: The mediating role of expectations in the experience of side effects in anxious patients treated with secukinumab. [PDF]
Brain Behav Immun HealthMühlhaus S +5 more
europepmc +1 more source
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent. [PDF]
BioDrugs, 2018 Kristensen LE +8 more
europepmc +1 more source